semaglutide compound tablets Novo Nordisk medicines containing I've Been Taking Compounded Semaglutide
Description
In 2024, it was also approved to Zepbound treat obstructive sleep apnea in adults with obesity
The most common adverse effects include nausea, vomiting, and diarrhea, which usually improve over time
Beyond weight loss, semaglutide improved cardiovascular risk factors including blood pressure, cholesterol levels, and hemoglobin A1C in people with type 2 diabetes
Other Reported Vision Issues From Wegovy In addition to NAION, people with diabetes or cardiovascular risk factors who take Wegovy may still be at risk for other common eye conditions such as diabetic retinopathy, macular edema, or ocular migraines (although these conditions can occur in people not taking Wegovy)
It clearly shows how GLP-1s affect the reward system of the brain
